PAR 5.00% 19.0¢ paradigm biopharmaceuticals limited..

Ann: iPPS SIGNIFICANT OA PAIN REDUCTION AT 12 MONTHS, page-76

  1. 353 Posts.
    lightbulb Created with Sketch. 399
    That image tells it all. Although I know BP probably prefer it the other way around so they can sell quantity, this is what the FDA will want to see.
    Fentanyl may have become the new leading killer of people, but it still starts with people being overprescribed pain medication who turn to heroin and fentanyl when they get cut off from oxy.

    I think it pays to remember that we haven't even done a P3 yet, this has all been P2 and below which is excellent imo
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.